Why tetracycline for acne

I have had several in the past few months, and to be truthful, I had no idea what it was. Patients I have seen are using it on their faces for wrinkles, on their scars and on stretch marks. Some have said they take Specialties Autoimmune. Clinical Pathways. Population Health. Public Safety. Wound Care. Publications Addiction Professional. Annals of Long-Term Care. Behavioral Healthcare Executive. Cath Lab Digest. EP Lab Digest. First Report Managed Care. Integrated Healthcare Executive.

IO Learning. Journal of Clinical Pathways. Journal of Invasive Cardiology. Pharmacy Learning Network. Podiatry Today. Psych Congress Network. Today's Wound Clinic. Vascular Disease Management. Veterans Health Today.

Advances in Inflammatory Bowel Disease. Advances in Inflammatory Bowel Disease Regionals. AMP Europe. Amputation Prevention Symposium. Cape Cod Symposium on Addictive Disorders. EMS World Expo. Evolution of Psychotherapy. Great Debates and Updates in Gastrointestinal Malignancies.

Great Debates and Updates in Hematologic Malignancies. Great Debates and Updates in Oncology Pharmacy. International Symposium on Endovascular Therapy.

Lymphoma, Leukemia and Myeloma. NCAD East. Oncology Clinical Pathways Congress. Personalized Therapies in Thoracic Oncology. Post Acute Care Symposium. Practical Updates In Primary Care. Psych Congress. Psych Congress Elevate. Psych Congress Regionals. Rocky Mountain Symposium.

Sana Symposium Psychedelics Newsroom. Symposium on Advanced Wound Care. Symposium on Clinical Interventional Oncology. Another tetracycline, sarecycline, was approved last year by the FDA for moderate-to-severe acne vulgaris in patients aged 9 years of age and older. Sarecycline possesses anti-inflammatory properties and potent activity against Gram-positive bacteria, including activity against multiple strains of Cutibacterium acnes , while exhibiting minimal activity against enteric aerobic Gram-negative bacteria.

While sarecycline demonstrated comparable efficacy to doxycycline and tetracycline against C. It is believed that disruption of gastrointestinal tract microbiota associated with use of doxycycline and minocycline may contribute to the increased incidence of gastrointestinal side effects, diarrhea, intestinal and vaginal fungal overgrowth and vaginal candidiasis, particularly in patients receiving prolonged oral therapy. Multidrug-resistant Gram-negative infections are increasingly prevalent and a source of major morbidity and mortality.

Tetracycline, doxycycline and minocycline also cross the blood—brain barrier, which may explain the potential side effects of pseudotumor cerebri, headaches and dizziness, whereas as sarecycline is less likely to cross the blood—brain barrier. Because no difference in bioavailability was observed when taken with food, sarecycline has FDA approval to be taken with or without food, without any warnings to avoid food, iron, antacids or calcium supplements, unlike other antibiotics in the tetracycline family.

Tetracyclines generally need to be taken with a full glass of water, either two hours after eating or two hours before eating because they bind with food and also easily with magnesium, aluminium, iron and calcium, which reduces their ability to be completely absorbed by the body.

Older tetracyclineclass antibiotics have been linked to staining of permanent teeth in children, 3 and subsequently tetracycline antibiotics have been licensed for use only in children above the age of 8, when the period of odontogenosis ends. Sarecycline is a viable treatment option for prepubertal children, Dr. Moore says. Multiple studies have been published showing that use of doxycycline before 8 years of age show no sign of permanent teeth staining.

The efficacy and safety profiles of sarecycline were evaluated in two identically designed, multicenter, double-blind, Phase 3 studies involving patients aged between the ages of 9 and 45 years of age with moderate-to-severe acne vulgaris.

We conducted a systematic search of PubMed to identify large interventional and observational studies utilizing oral tetracyclines as an acne treatment. We identified 13 articles meeting inclusion for this review, which represented , pediatric and adult acne patients. Oral tetracyclines that were included in this systematic review were sarecycline a novel narrow-spectrum tetracycline , doxycycline, minocycline, and tetracycline.

Based on shared and divergent outcome measures, different oral tetracyclines were variably effective against facial acne.